RETRACTION article

Front. Immunol., 25 September 2024

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1495479

Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma

The journal retracts the April 2022 article cited above.

Following publication, concerns were raised regarding the validity of the data in the article. An investigation by our internal Research Integrity department, conducted in accordance with Frontiers policies, was unable to confirm the validity of the data presented and we cannot vouch for its reliability. The article is therefore retracted.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Summary

Keywords

hepatocellular carcinoma (HCC), Girders of actin filaments (CCDC88A), vascular endothelial growth factor (VEGF), MicroRNA-101, Malignant behavior, Cancer stem-like cells (CSCs)

Citation

Frontiers Editorial Office (2024) Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma. Front. Immunol. 15:1495479. doi: 10.3389/fimmu.2024.1495479

Received

12 September 2024

Accepted

13 September 2024

Published

25 September 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics